-
News from the Pacific Northwest Node: Two New Publications about CTN-0082
The PNW Node has two new publications out, both related to CTN-0082: “Not a monolith”: Type-specific MOUD awareness and rural willingness among direct service providers and clients. Laschober TC, et al. Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 14-17, 2026. This poster describes the results of a survey of CBO providers and clients across 13 Southern U.S. CBOs (FL, GA, LA, MS, and TN) that found that, compared with methadone, buprenorphine and naltrexone awareness was lower for both providers and clients, though providers were more aware of all types of medications for opioid use disorder (MOUD) than clients. Additionally, providers reported greater willingness to refer for buprenorphine and naltrexone than clients reported willingness to be referred. These types of misalignments can hinder MOUD uptake and contribute to high overdose rates and limited MOUD access in the South. Perceived effect of the COVID-19 pandemic on substance use and interest in medications for opioid use disorder and naloxone among people who use opioids in the Southern United States. Laschober TC, et al. Journal of Prevention and Health Promotion 2026 (in press). This paper describes a study looking at the effects of the pandemic on self-reported change in drug and alcohol use and medications for opioid use disorder (MOUD) and naloxone interest in a population and region hit hard by the opioid crisis: people who use illicit opioids. Results found no significant change in use of opioids, non-opioid drugs, or alcohol, and interest in MOUD…
-
New in the Library (May – June 2026)
Here are the latest items added to the CTN Dissemination Library for May – June 2026 (this post will be updated as new items come in): “Not a monolith”: Type-specific MOUD awareness and rural willingness among direct service providers and clients. Laschober TC, et al. Poster presented at the College on Problems of Drug Dependence (CPDD) annual meeting, June 14-17, 2026. (CTN-0082) Fentanyl overdose history and cocaine use severity are associated with how people mitigate risks of fentanyl-adulterated cocaine. Anighoro B, et al. Substance Use & Misuse 2026 (in press). (CTN-0130) Perceived effect of the COVID-19 pandemic on substance use and interest in medications for opioid use disorder and naloxone among people who use opioids in the Southern United States. Laschober TC, et al. Journal of Prevention and Health Promotion 2026 (in press). (CTN-0082) Emergency department-initiated standard versus high-dose buprenorphine induction (ENVISION): A randomised clinical trial protocol. Hawk K, et al. BMJ Open 2026;16(6):e113762. (CTN-0145) Characterization of patients declining to participate in opioid overdose prevention clinical research in an emergency department setting. Ward RC, et al. Journal of Substance Use & Addiction Treatment 2026 (in press). (CTN-0107) Overcoming low representation: Lessons from an integrative data analysis of CTN studies for assessing treatment effectiveness among Black people who use cocaine and/or opioids. Ruglass LM, et al. Journal of Substance Use & Addiction Treatment 2026 (in press). (CTN-0125) Longitudinal craving profiles in cannabis use disorder: A latent class growth analysis of the achieving cannabis cessation: Evaluating N-Acetylcysteine Treatment (ACCENT) (CTN-0053) trial.…
